Regorafenib Reverses Temozolomide-Induced CXCL12/CXCR4 Signaling and Triggers Apoptosis Mechanism in Glioblastoma

I‐Tsang Chiang(Chang Bing Show Chwan Memorial Hospital), Fei‐Ting Hsu(National Central University)
Neurotherapeutics
March 1, 2022
Cited by 27


Related Papers